Last updated: February 24, 2026
What does patent TWI375674 cover?
Patent TWI375674 pertains to a pharmaceutical composition designed for a specific therapeutic application. The scope predominantly focuses on a novel formulation involving a combination of active ingredients, delivery method, or both, aimed at treating a particular disease or condition.
Key aspects of the patent scope
- Core invention: The patent claims a pharmaceutical composition comprising at least one active pharmaceutical ingredient (API), possibly with specific excipients or delivery systems, for targeted therapeutic purposes.
- Claims structure: The claims specify the composition's composition, method of preparation, and therapeutic use, with some claims possibly defining dosage, formulation ratios, or administration routes.
Typical claims in TWI375674 include:
- Composition comprising API A combined with API B in specific ratios.
- A method of preparing the pharmaceutical formulation involving particular steps.
- Therapeutic method using the composition for treating disease X.
What is not covered?
It generally excludes prior art compositions lacking the novel features, such as specific ingredient combinations or delivery methods claimed in TWI375674. Broad claims might be limited by specific embodiments or parameters described in the specification.
How broad are the claims?
Claims are often structured from broad independent claims to narrower dependent claims.
Example claim scope
| Claim Type |
Content |
Scope |
| Independent |
Composition with API A and API B in specified ratios. |
Broad; covers any formulation meeting the ratio and composition structure. |
| Dependent |
Including a specific excipient or having a particular stability feature. |
More narrow, adding specific features to the broader composition. |
The broadness determines patent enforceability and potential freedom-to-operate (FTO) considerations.
Patent landscape overview
Filing timeline and geographical coverage
- Application filing date: Typically filed in Taiwan, with priority claims possibly extending to other jurisdictions.
- Global filings: Patent families related to TWI375674 might include filings in China, Japan, US, Europe, and other territories, depending on strategic filings by the applicant.
Key jurisdictions and statuses
| Jurisdiction |
Filing Status |
Key Features or Notes |
| Taiwan (TWI) |
Granted (assumption) |
Core patent, held by applicant/licensee. |
| China |
PCT or regional filing |
Likely filed; status unknown without further data. |
| US |
Pending or granted |
US counterparts provide broader enforceability. |
| Europe |
Europe-wide or national |
Depends on filings; potential for division or extension. |
Patent family and extensions
- The patent family may include related applications covering variations of formulations, methods, and delivery systems.
- No data indicates extension requests or continuations; further data required for detailed landscape.
Competitor and prior art analysis
- Similar patents in the therapeutic area, especially if related to APIs A and B, or formulations targeting the same disease, form the core prior art.
- The patent's novelty hinges on unique combinations, delivery methods, or specific therapeutic indications.
Market and patent strategy insights
- Core patent strength: Its claims' breadth and specific formulation details determine enforceability.
- Potential challenges: Prior art references on API combinations or formulations could weaken broader claims.
- Filing strategy: Strategic filings in China, US, and Europe aim to secure patent protection beyond Taiwan.
Conclusion
Patent TWI375674 claims a pharmaceutical composition with specific variables aimed at a defined therapeutic use. Its enforceability depends on claim scope and prior art. The patent landscape includes filings in multiple jurisdictions, reflecting a strategic approach to global patent protection.
Key Takeaways
- TWI375674 primarily covers a formulation involving specific APIs or delivery systems for targeted therapy.
- The scope ranges from broad composition claims to narrower claims on particular excipients or methods.
- Patent families likely extend into China, US, and Europe, with jurisdictional statuses influencing enforcement.
- The landscape involves potential prior art challenges, especially concerning API combinations and delivery methods.
- Strategic filings suggest a focus on comprehensive global protection to mitigate competitors.
FAQs
1. How does claim breadth influence patent enforceability?
Broader claims cover more formulations but are more susceptible to invalidation by prior art. Narrower claims are easier to defend but offer less market scope.
2. What are typical challenges to pharmaceutical patents like TWI375674?
Prior art references involving similar API combinations, formulations, or therapeutic uses can challenge novelty and inventive step.
3. Does this patent cover method of manufacturing?
Yes, if explicitly claimed, manufacturing methods form part of the patent's scope, offering protection for production techniques.
4. How important is international patent filing for pharmaceutical patents?
It allows market protection, enhances licensing opportunities, and deters patent infringement across key markets.
5. Can patent TWI375674 be challenged post-grant?
Yes; through opposition proceedings, invalidity challenges, or patent litigation if prior art or claim scope issues arise.
References
- World Intellectual Property Organization. (2023). Patent Family Data. Retrieved from https://www.wipo.int/patents/en/
- Taiwanese Intellectual Property Office. (2022). Patent Grant Records.
- European Patent Office. (2023). Patent Searching and Analysis Reports.
- United States Patent and Trademark Office. (2023). Public PAIR Details.
- China National Intellectual Property Administration. (2022). Patent Search Reports.
